Dalton, David2014-12-302014-12-302014-12-18http://hdl.handle.net/123456789/10150The production of the most widely used medical radioisotope, molybdenum-99 (Mo-99), depends largely on a small number of reactors that are ageing and facing unplanned outages, refurbishment outages or permanent shutdowns, increasing the risk of disruption to the supply chain, a joint declaration signed by 11 countries says.28907 bytesapplication/pdfenOther